Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation.
Saved in:
| Title: | Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation. |
|---|---|
| Authors: | El-Chemaly S; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., O'Brien KJ; Office of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Nathan SD; Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia, United States of America., Weinhouse GL; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Goldberg HJ; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Connors JM; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Cui Y; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Astor TL; Division of Pulmonary & Critical Care Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Camp PC Jr; Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Rosas IO; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Lemma M; Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia, United States of America., Speransky V; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, United States of America., Merideth MA; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Gahl WA; Office of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Gochuico BR; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America. |
| Source: | PloS one [PLoS One] 2018 Mar 16; Vol. 13 (3), pp. e0194193. Date of Electronic Publication: 2018 Mar 16 (Print Publication: 2018). |
| Publication Type: | Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0194193 |
